Related Experiment Video
Updated: Feb 3, 2026

13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
24.7K
Hepatitis E Virus-Associated Acute Encephalitic Parkinsonism.
Shaik Afsar Pasha1, Shaik Arif Pasha2, T Suhasini2
1Associate Professor, Department of Neurology.
The Journal of the Association of Physicians of India
|October 21, 2018
Summary
Hepatitis E virus (HEV) infection can cause neurological problems like Parkinsonism, even with liver issues. Early HEV testing is recommended for patients with neurological disorders and liver impairment.
Area of Science:
- Hepatology
- Neurology
- Infectious Diseases
Background:
- Hepatitis E virus (HEV) is a global pathogen with distinct epidemiological and clinical profiles in developed versus developing nations.
- Neurological complications are increasingly recognized as extrahepatic manifestations of both acute and chronic HEV infections.
- HEV is an emerging infectious disease in developed countries, necessitating a broader understanding of its clinical spectrum.
Observation:
- A 17-year-old athlete presented with acute encephalitic Parkinsonism coinciding with acute hepatitis.
- Diagnostic serology confirmed Hepatitis E virus (HEV) infection, and HEV RNA was detected.
- The patient experienced a full recovery with supportive and symptomatic management.
Findings:
- This case highlights a rare presentation of HEV-associated neurological disorder, specifically acute encephalitic Parkinsonism.
- Concurrent hepatitis and neurological symptoms in a young patient strongly suggested an infectious etiology.
- Confirmation of HEV infection via serology and RNA detection established the causative agent.
Implications:
- The findings suggest that HEV should be considered in the differential diagnosis of patients presenting with neurological disorders, particularly when accompanied by liver impairment.
- Diagnostic testing for HEV may be beneficial for patients with unexplained neurological conditions and concurrent liver dysfunction.
- This case underscores the importance of recognizing HEV's potential for diverse extrahepatic manifestations, including severe neurological syndromes.
Related Concept Videos
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
What are Viruses?
128.2K
Overview
128.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
280
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
280
Hepatic Portal System
5.9K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.9K
Parkinson's Disease: Overview
2.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
244
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
244

